TY - T1的历史影响肺结核结核分枝杆菌特异性的爱视宝/ RIF JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.00343 -2020欧元SP - 2000343 AU -弗雷德里克Haraka AU -塞缪尔·G舒马赫AU -阿曼达罗斯Sebastien Gagneux AU -安娜Mantsoki盟盟-克劳斯赖泽盟克劳迪娅M Denkinger Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/early/2020/04/29/13993003.00343 - 2020. -抽象N2 -肺结核(TB)是传染病的死亡率的主要原因。2018年,150万人死于结核[1]。早期诊断结核病的关键是实现人结核病目标和分子诊断测试已经开发出来。然而,有活力和无活力细菌分子测试不能区分(2、3),导致挑战积极的测试结果的解释最近的结核病患者。FootnotesThis手稿最近发表在《欧洲呼吸杂志》上。这里发表周全之前接受的形式排版,我们的生产团队。这些生产过程完成后,作者已经批准结果证明,本文将最新一期的ERJ在线。请打开或下载PDF查看这篇文章。利益冲突:Haraka博士没有披露。利益冲突:Denkinger博士报告为找到工作,直到2019年4月。发现是一个非营利性基金会的使命是寻找诊断解决中低收入国家建设克服贫穷疾病。 It works closely with the private and public sectors and receives funding from some of its industry partners. It has organizational firewalls to protect it against any undue influences in its work or the publication of its findings. All industry partnerships are subject to review by an independent Scientific Advisory Committee or another independent review body, based on due diligence, TTPs and public sector requirements. FIND catalyzes product development, leads evaluations, takes positions, and accelerates access to tools identified as serving its mission. It provides indirect support to industry (e.g., access to open specimen banks, a clinical trial platform, technical support, expertise, laboratory capacity strengthening in LMICs, etc.) to facilitate the development and use of products in these areas. FIND also supports the evaluation of prioritized assays and the early stages of implementation of WHO-approved (guidance & PQ) assays using donor grants. In order to carry out test validations and evaluations, has product evaluation agreements with several private sector companies for the diseases FIND works in which strictly define its independence and neutrality vis-a-vis the companies whose products get evaluated, and describes roles and responsibilities.Conflict of interest: Dr. Ross has nothing to disclose.Conflict of interest: Dr. Mantsoki has nothing to disclose.Conflict of interest: Dr. Gagneux has nothing to disclose.Conflict of interest: Dr. Reither has nothing to disclose. ER -